Global Retirement Partners, LLC Immuno Gen, Inc. Transaction History

Global Retirement Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$12.46 - $29.95 $161 - $389	13 New	13 $0
Q2 2020 Jul 13, 2020	SELL	$3.32 - $5.34 $873 - $1,404	-263 Closed	0 $0
Q3 2019 Nov 19, 2019	SELL	$2.22 - $3.39 $419 - $640	-189 Reduced 41.81%	263 $1,000
Q2 2019 Nov 19, 2019	BUY	$1.8 - $3.3 $315 - $577	175 Added 63.18%	452 $1,000
Q4 2018 Feb 22, 2019	BUY	$3.94 - $9.7 $193 - $475	49 Added 21.49%	277 $1,000
Q3 2018 Oct 17, 2018	BUY	$8.6 - $11.26 $163 - $213	19 Added 9.09%	228 $2,000
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $1,151 - $1,470	121 Added 137.5%	209 $2,000
Q1 2018 Aug 10, 2018	BUY	$6.7 - $12.95 $589 - $1,139	88 New	88 $1,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.